On January 1, 2023, HHSC will designate one medication as the primary preferred direct-acting antiviral (DAA) drug option for treating Hepatitis C infection. HHSC will designate all other DAA drugs on the Medicaid formulary as non-preferred. All Medicaid clients are...
Texas Medicaid implemented a medical benefit for the CoCM on June 1, 2022, as directed by Senate Bill 672, 87th Legislature, Regular Session, 2021. Prior to the implementation of the benefit, HHSC conducted two trainings on CoCM services for MCOs in May of 2022. To...
There will be revisions to the Electronic Visit Verification (EVV) Policy Handbook, these revisions will publish and be effective on Sept. 1, 2022. The handbook includes EVV standards and policy requirements for: Program Providers Financial Management Services...
Community First will not be requiring authorization for behavioral health services that are managed by and billed by the patient’s PCP. This is part of the Collaborative Care Model (CoCM). Senate Bill 672, 87th Legislature, Regular Session, 2021 directed HHSC to...
In response to the COVID-19 public health emergency, HHSC waived copayments for office visits beginning in March 2020. To comply with the Mental Health Parity and Addiction Equality Act (Pub. L. 110-343), HHSC is prohibiting co-payments for CHIP Mental Health and...
HHSC is postponing the Electronic Visit Verification Required Free Text Reviews for the Consumer Directed Services option starting with dates of service Jan. 1, 2022, until further notice. HHSC will publish a notice 90 days before the effective date when EVV Required...